| Line Item | 2024-08-31 | Y/Y |
|---|---|---|
| Revenue | $70.0M | +17.5% |
| Cost of Revenue | $26.9M | +131.0% |
| Gross Profit | $43.2M | -10.0% |
| R&D Expense | $5.8M | +27.8% |
| SG&A Expense | $22.4M | -35.6% |
| Operating Income | $6.1M | -29.7% |
| Pre-tax Income | $12.4M | +6.1% |
| Income Tax | $2.5M | +41.7% |
| Net Income | $10.0M |
| Line Item | 2024-08-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.3M | -82.1% |
| Short-term Investments | $9.9M | -82.8% |
| Accounts Receivable | $9.1M | -10.4% |
| Current Assets | $39.3M | -69.8% |
| Total Assets | $196.6M | +5.7% |
| Current Liabilities | $12.1M | +0.7% |
| Total Liabilities | $14.2M | -11.6% |
| Line Item | 2024-08-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $13.3M | -39.1% |
| Capital Expenditures | $566K | +24.9% |
| Investing Cash Flow | -$54.0M | -832.7% |
| Financing Cash Flow | -$6.6M | +71.8% |
| Free Cash Flow | $12.8M | -40.4% |
| -0.1% |
| EPS (Basic) | $0.50 | +0.0% |
| EPS (Diluted) | $0.49 | +0.0% |
| Stockholders' Equity |
| $182.4M |
| +7.3% |